Tilray Calling On Shareholders To Support Dilution, Proxy Advisory Firm Joins The Plea Ahead Of Upcoming Shareholders Meeting

Canadian cannabis giant Tilray, Inc. TLRY confirmed Wednesday that another independent proxy advisory firm is recommending that shareholders back all the company’s proposals at a special meeting scheduled for July 29. This time, the proxy advisory services company Glass Lewis also advised shareholders to vote in favor of the company’s dilution as well as other proposals

Tilray, based in New York and Leamington, Ontario, previously released a proxy statement with an open letter from CEO Irwin D. Simon in which he called on shareholders to support proposals to be discussed up at the upcoming annual shareholders meeting

Some two weeks later, Tilray announced that Institutional Shareholder Services (ISS), an independent proxy advisory firm, recommended Tilray shareholders approve the company’s propositions

“We are pleased that the two major independent proxy advisory firms both agree that shareholders should support all of the proposals on the agenda for the upcoming Special Meeting of shareholders,” Irwin D. Simon, Tilray’s chairman and CEO stated. “Proposal 1, in particular, is a critical part of our strategy to capture market share and drive profitable growth. Glass Lewis’ endorsement affirms our conviction that Proposal 1 is in the best interest of our shareholders.”

Simon continued, “By approving all of the proposals on the agenda, our shareholders will be actively participating in Tilray’s ability to capitalize on substantial growth opportunities, expand and generate strong performance, increase shareholder rights and, ultimately, drive shareholder value.”

‘A Reasonable Proposal’ 

In relation to proposal 1, Glass Lewis told shareholders: “Given the relatively limited amount of shares available to the Company, we believe that it may be prudent for the Company to have additional common shares available for issuance.”

On the same matter, ISS previously stated: “The size of the proposed increase in the number of authorized shares of common stock is reasonable and there are no substantial concerns with the company's past use of shares.”

In conclusion, Tilray' Simon is urging shareholders to support these important steps to ensure the company’s strategic development and to advance shareholder rights.

Your support is important, no matter how many or how few shares you own,” Tilray said in a press release.

Price Action 

Tilray’s shares closed Wednesday’s market session 3.11% higher at $14.60 per share. 

Photo: Courtesy of CRYSTALWEED cannabis on Unsplash

Posted In: Glass LewisInstitutional Shareholder ServicesIrwin D. SimonTilray dilutionTilray speical meetingCannabisNewsMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.